The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Eprosartan Mesylate Market Research Report 2025
Synopsis
The global Eprosartan Mesylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eprosartan Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eprosartan Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eprosartan Mesylate include Abbott, Viatris (Mylan), The United States Pharmacopeial Convention, Unichem Laboratories and Jubilant Generics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eprosartan Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eprosartan Mesylate.
Report Scope
The Eprosartan Mesylate market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eprosartan Mesylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eprosartan Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Viatris (Mylan)
The United States Pharmacopeial Convention
Unichem Laboratories
Jubilant Generics
Segment by Type
200mg
400mg
Segment by Application
Hypertension Diagnosis
Heart Failure Diagnosis
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eprosartan Mesylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Eprosartan Mesylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Eprosartan Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Eprosartan Mesylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eprosartan Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eprosartan Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eprosartan Mesylate include Abbott, Viatris (Mylan), The United States Pharmacopeial Convention, Unichem Laboratories and Jubilant Generics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eprosartan Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eprosartan Mesylate.
Report Scope
The Eprosartan Mesylate market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eprosartan Mesylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eprosartan Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Viatris (Mylan)
The United States Pharmacopeial Convention
Unichem Laboratories
Jubilant Generics
Segment by Type
200mg
400mg
Segment by Application
Hypertension Diagnosis
Heart Failure Diagnosis
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eprosartan Mesylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Eprosartan Mesylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Eprosartan Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Eprosartan Mesylate Market Overview
1.1 Product Definition
1.2 Eprosartan Mesylate Segment by Type
1.2.1 Global Eprosartan Mesylate Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 200mg
1.2.3 400mg
1.3 Eprosartan Mesylate Segment by Application
1.3.1 Global Eprosartan Mesylate Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Hypertension Diagnosis
1.3.3 Heart Failure Diagnosis
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Eprosartan Mesylate Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Eprosartan Mesylate Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Eprosartan Mesylate Production Estimates and Forecasts (2019-2030)
1.4.4 Global Eprosartan Mesylate Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Eprosartan Mesylate Production Market Share by Manufacturers (2019-2024)
2.2 Global Eprosartan Mesylate Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Eprosartan Mesylate, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Eprosartan Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Eprosartan Mesylate Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Eprosartan Mesylate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Eprosartan Mesylate, Product Offered and Application
2.8 Global Key Manufacturers of Eprosartan Mesylate, Date of Enter into This Industry
2.9 Eprosartan Mesylate Market Competitive Situation and Trends
2.9.1 Eprosartan Mesylate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Eprosartan Mesylate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Eprosartan Mesylate Production by Region
3.1 Global Eprosartan Mesylate Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Eprosartan Mesylate Production Value by Region (2019-2030)
3.2.1 Global Eprosartan Mesylate Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Eprosartan Mesylate by Region (2025-2030)
3.3 Global Eprosartan Mesylate Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Eprosartan Mesylate Production by Region (2019-2030)
3.4.1 Global Eprosartan Mesylate Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Eprosartan Mesylate by Region (2025-2030)
3.5 Global Eprosartan Mesylate Market Price Analysis by Region (2019-2024)
3.6 Global Eprosartan Mesylate Production and Value, Year-over-Year Growth
3.6.1 North America Eprosartan Mesylate Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Eprosartan Mesylate Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Eprosartan Mesylate Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Eprosartan Mesylate Production Value Estimates and Forecasts (2019-2030)
4 Eprosartan Mesylate Consumption by Region
4.1 Global Eprosartan Mesylate Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Eprosartan Mesylate Consumption by Region (2019-2030)
4.2.1 Global Eprosartan Mesylate Consumption by Region (2019-2024)
4.2.2 Global Eprosartan Mesylate Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Eprosartan Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Eprosartan Mesylate Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Eprosartan Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Eprosartan Mesylate Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Eprosartan Mesylate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Eprosartan Mesylate Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Eprosartan Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Eprosartan Mesylate Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Eprosartan Mesylate Production by Type (2019-2030)
5.1.1 Global Eprosartan Mesylate Production by Type (2019-2024)
5.1.2 Global Eprosartan Mesylate Production by Type (2025-2030)
5.1.3 Global Eprosartan Mesylate Production Market Share by Type (2019-2030)
5.2 Global Eprosartan Mesylate Production Value by Type (2019-2030)
5.2.1 Global Eprosartan Mesylate Production Value by Type (2019-2024)
5.2.2 Global Eprosartan Mesylate Production Value by Type (2025-2030)
5.2.3 Global Eprosartan Mesylate Production Value Market Share by Type (2019-2030)
5.3 Global Eprosartan Mesylate Price by Type (2019-2030)
6 Segment by Application
6.1 Global Eprosartan Mesylate Production by Application (2019-2030)
6.1.1 Global Eprosartan Mesylate Production by Application (2019-2024)
6.1.2 Global Eprosartan Mesylate Production by Application (2025-2030)
6.1.3 Global Eprosartan Mesylate Production Market Share by Application (2019-2030)
6.2 Global Eprosartan Mesylate Production Value by Application (2019-2030)
6.2.1 Global Eprosartan Mesylate Production Value by Application (2019-2024)
6.2.2 Global Eprosartan Mesylate Production Value by Application (2025-2030)
6.2.3 Global Eprosartan Mesylate Production Value Market Share by Application (2019-2030)
6.3 Global Eprosartan Mesylate Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Abbott
7.1.1 Abbott Eprosartan Mesylate Corporation Information
7.1.2 Abbott Eprosartan Mesylate Product Portfolio
7.1.3 Abbott Eprosartan Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Abbott Main Business and Markets Served
7.1.5 Abbott Recent Developments/Updates
7.2 Viatris (Mylan)
7.2.1 Viatris (Mylan) Eprosartan Mesylate Corporation Information
7.2.2 Viatris (Mylan) Eprosartan Mesylate Product Portfolio
7.2.3 Viatris (Mylan) Eprosartan Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Viatris (Mylan) Main Business and Markets Served
7.2.5 Viatris (Mylan) Recent Developments/Updates
7.3 The United States Pharmacopeial Convention
7.3.1 The United States Pharmacopeial Convention Eprosartan Mesylate Corporation Information
7.3.2 The United States Pharmacopeial Convention Eprosartan Mesylate Product Portfolio
7.3.3 The United States Pharmacopeial Convention Eprosartan Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.3.4 The United States Pharmacopeial Convention Main Business and Markets Served
7.3.5 The United States Pharmacopeial Convention Recent Developments/Updates
7.4 Unichem Laboratories
7.4.1 Unichem Laboratories Eprosartan Mesylate Corporation Information
7.4.2 Unichem Laboratories Eprosartan Mesylate Product Portfolio
7.4.3 Unichem Laboratories Eprosartan Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Unichem Laboratories Main Business and Markets Served
7.4.5 Unichem Laboratories Recent Developments/Updates
7.5 Jubilant Generics
7.5.1 Jubilant Generics Eprosartan Mesylate Corporation Information
7.5.2 Jubilant Generics Eprosartan Mesylate Product Portfolio
7.5.3 Jubilant Generics Eprosartan Mesylate Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Jubilant Generics Main Business and Markets Served
7.5.5 Jubilant Generics Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Eprosartan Mesylate Industry Chain Analysis
8.2 Eprosartan Mesylate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Eprosartan Mesylate Production Mode & Process
8.4 Eprosartan Mesylate Sales and Marketing
8.4.1 Eprosartan Mesylate Sales Channels
8.4.2 Eprosartan Mesylate Distributors
8.5 Eprosartan Mesylate Customers
9 Eprosartan Mesylate Market Dynamics
9.1 Eprosartan Mesylate Industry Trends
9.2 Eprosartan Mesylate Market Drivers
9.3 Eprosartan Mesylate Market Challenges
9.4 Eprosartan Mesylate Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Eprosartan Mesylate Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Eprosartan Mesylate Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Eprosartan Mesylate Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Eprosartan Mesylate Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Eprosartan Mesylate Production Market Share by Manufacturers (2019-2024)
Table 6. Global Eprosartan Mesylate Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Eprosartan Mesylate Production Value Share by Manufacturers (2019-2024)
Table 8. Global Eprosartan Mesylate Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eprosartan Mesylate as of 2023)
Table 10. Global Market Eprosartan Mesylate Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Eprosartan Mesylate Production Sites and Area Served
Table 12. Manufacturers Eprosartan Mesylate Product Types
Table 13. Global Eprosartan Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Eprosartan Mesylate Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Eprosartan Mesylate Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Eprosartan Mesylate Production Value Market Share by Region (2019-2024)
Table 18. Global Eprosartan Mesylate Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Eprosartan Mesylate Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Eprosartan Mesylate Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 21. Global Eprosartan Mesylate Production (Tons) by Region (2019-2024)
Table 22. Global Eprosartan Mesylate Production Market Share by Region (2019-2024)
Table 23. Global Eprosartan Mesylate Production (Tons) Forecast by Region (2025-2030)
Table 24. Global Eprosartan Mesylate Production Market Share Forecast by Region (2025-2030)
Table 25. Global Eprosartan Mesylate Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Eprosartan Mesylate Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Eprosartan Mesylate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 28. Global Eprosartan Mesylate Consumption by Region (2019-2024) & (Tons)
Table 29. Global Eprosartan Mesylate Consumption Market Share by Region (2019-2024)
Table 30. Global Eprosartan Mesylate Forecasted Consumption by Region (2025-2030) & (Tons)
Table 31. Global Eprosartan Mesylate Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Eprosartan Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 33. North America Eprosartan Mesylate Consumption by Country (2019-2024) & (Tons)
Table 34. North America Eprosartan Mesylate Consumption by Country (2025-2030) & (Tons)
Table 35. Europe Eprosartan Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 36. Europe Eprosartan Mesylate Consumption by Country (2019-2024) & (Tons)
Table 37. Europe Eprosartan Mesylate Consumption by Country (2025-2030) & (Tons)
Table 38. Asia Pacific Eprosartan Mesylate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 39. Asia Pacific Eprosartan Mesylate Consumption by Region (2019-2024) & (Tons)
Table 40. Asia Pacific Eprosartan Mesylate Consumption by Region (2025-2030) & (Tons)
Table 41. Latin America, Middle East & Africa Eprosartan Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 42. Latin America, Middle East & Africa Eprosartan Mesylate Consumption by Country (2019-2024) & (Tons)
Table 43. Latin America, Middle East & Africa Eprosartan Mesylate Consumption by Country (2025-2030) & (Tons)
Table 44. Global Eprosartan Mesylate Production (Tons) by Type (2019-2024)
Table 45. Global Eprosartan Mesylate Production (Tons) by Type (2025-2030)
Table 46. Global Eprosartan Mesylate Production Market Share by Type (2019-2024)
Table 47. Global Eprosartan Mesylate Production Market Share by Type (2025-2030)
Table 48. Global Eprosartan Mesylate Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Eprosartan Mesylate Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Eprosartan Mesylate Production Value Share by Type (2019-2024)
Table 51. Global Eprosartan Mesylate Production Value Share by Type (2025-2030)
Table 52. Global Eprosartan Mesylate Price (US$/Ton) by Type (2019-2024)
Table 53. Global Eprosartan Mesylate Price (US$/Ton) by Type (2025-2030)
Table 54. Global Eprosartan Mesylate Production (Tons) by Application (2019-2024)
Table 55. Global Eprosartan Mesylate Production (Tons) by Application (2025-2030)
Table 56. Global Eprosartan Mesylate Production Market Share by Application (2019-2024)
Table 57. Global Eprosartan Mesylate Production Market Share by Application (2025-2030)
Table 58. Global Eprosartan Mesylate Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Eprosartan Mesylate Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Eprosartan Mesylate Production Value Share by Application (2019-2024)
Table 61. Global Eprosartan Mesylate Production Value Share by Application (2025-2030)
Table 62. Global Eprosartan Mesylate Price (US$/Ton) by Application (2019-2024)
Table 63. Global Eprosartan Mesylate Price (US$/Ton) by Application (2025-2030)
Table 64. Abbott Eprosartan Mesylate Corporation Information
Table 65. Abbott Specification and Application
Table 66. Abbott Eprosartan Mesylate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Abbott Main Business and Markets Served
Table 68. Abbott Recent Developments/Updates
Table 69. Viatris (Mylan) Eprosartan Mesylate Corporation Information
Table 70. Viatris (Mylan) Specification and Application
Table 71. Viatris (Mylan) Eprosartan Mesylate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Viatris (Mylan) Main Business and Markets Served
Table 73. Viatris (Mylan) Recent Developments/Updates
Table 74. The United States Pharmacopeial Convention Eprosartan Mesylate Corporation Information
Table 75. The United States Pharmacopeial Convention Specification and Application
Table 76. The United States Pharmacopeial Convention Eprosartan Mesylate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. The United States Pharmacopeial Convention Main Business and Markets Served
Table 78. The United States Pharmacopeial Convention Recent Developments/Updates
Table 79. Unichem Laboratories Eprosartan Mesylate Corporation Information
Table 80. Unichem Laboratories Specification and Application
Table 81. Unichem Laboratories Eprosartan Mesylate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Unichem Laboratories Main Business and Markets Served
Table 83. Unichem Laboratories Recent Developments/Updates
Table 84. Jubilant Generics Eprosartan Mesylate Corporation Information
Table 85. Jubilant Generics Specification and Application
Table 86. Jubilant Generics Eprosartan Mesylate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Jubilant Generics Main Business and Markets Served
Table 88. Jubilant Generics Recent Developments/Updates
Table 89. Key Raw Materials Lists
Table 90. Raw Materials Key Suppliers Lists
Table 91. Eprosartan Mesylate Distributors List
Table 92. Eprosartan Mesylate Customers List
Table 93. Eprosartan Mesylate Market Trends
Table 94. Eprosartan Mesylate Market Drivers
Table 95. Eprosartan Mesylate Market Challenges
Table 96. Eprosartan Mesylate Market Restraints
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Eprosartan Mesylate
Figure 2. Global Eprosartan Mesylate Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Eprosartan Mesylate Market Share by Type: 2023 VS 2030
Figure 4. 200mg Product Picture
Figure 5. 400mg Product Picture
Figure 6. Global Eprosartan Mesylate Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Eprosartan Mesylate Market Share by Application: 2023 VS 2030
Figure 8. Hypertension Diagnosis
Figure 9. Heart Failure Diagnosis
Figure 10. Others
Figure 11. Global Eprosartan Mesylate Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Eprosartan Mesylate Production Value (US$ Million) & (2019-2030)
Figure 13. Global Eprosartan Mesylate Production Capacity (Tons) & (2019-2030)
Figure 14. Global Eprosartan Mesylate Production (Tons) & (2019-2030)
Figure 15. Global Eprosartan Mesylate Average Price (US$/Ton) & (2019-2030)
Figure 16. Eprosartan Mesylate Report Years Considered
Figure 17. Eprosartan Mesylate Production Share by Manufacturers in 2023
Figure 18. Eprosartan Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. The Global 5 and 10 Largest Players: Market Share by Eprosartan Mesylate Revenue in 2023
Figure 20. Global Eprosartan Mesylate Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Eprosartan Mesylate Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Eprosartan Mesylate Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 23. Global Eprosartan Mesylate Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. North America Eprosartan Mesylate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Europe Eprosartan Mesylate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. China Eprosartan Mesylate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Japan Eprosartan Mesylate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Global Eprosartan Mesylate Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 29. Global Eprosartan Mesylate Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 31. North America Eprosartan Mesylate Consumption Market Share by Country (2019-2030)
Figure 32. Canada Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 33. U.S. Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 34. Europe Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 35. Europe Eprosartan Mesylate Consumption Market Share by Country (2019-2030)
Figure 36. Germany Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 37. France Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 38. U.K. Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 39. Italy Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 40. Russia Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 41. Asia Pacific Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 42. Asia Pacific Eprosartan Mesylate Consumption Market Share by Regions (2019-2030)
Figure 43. China Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 44. Japan Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 45. South Korea Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 46. China Taiwan Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 47. Southeast Asia Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 48. India Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 49. Latin America, Middle East & Africa Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 50. Latin America, Middle East & Africa Eprosartan Mesylate Consumption Market Share by Country (2019-2030)
Figure 51. Mexico Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 52. Brazil Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 53. Turkey Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 54. GCC Countries Eprosartan Mesylate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 55. Global Production Market Share of Eprosartan Mesylate by Type (2019-2030)
Figure 56. Global Production Value Market Share of Eprosartan Mesylate by Type (2019-2030)
Figure 57. Global Eprosartan Mesylate Price (US$/Ton) by Type (2019-2030)
Figure 58. Global Production Market Share of Eprosartan Mesylate by Application (2019-2030)
Figure 59. Global Production Value Market Share of Eprosartan Mesylate by Application (2019-2030)
Figure 60. Global Eprosartan Mesylate Price (US$/Ton) by Application (2019-2030)
Figure 61. Eprosartan Mesylate Value Chain
Figure 62. Eprosartan Mesylate Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
